Who should consider which Retatrutide isnt really an option in the UK in 2026 for anyone outside a clinical trial
The single most important fact to state at the outset is this: no head-to-head trial human or animal has ever compared BPC-157 against TB-500
6 Months and Beyond : Long-term users report dramatic transformations, with many achieving substantial weight loss when combined with lifestyle changes
When stratified by comparator groups, the pooled estimate was most favorable in monotherapy trials versus placebo (SMD 2.41, 95% CI 4.43 to 0.39), whereas the add-on designs versus the same background treatment (SMD 0.65, 95% CI 1.85 to 0.55), head-to-head comparisons versus another drug (SMD 0.19, 95% CI 0.84 to 0.45), and add-on designs versus placebo (SMD 0.65, 95% CI 1.35 to 0.06) showed more modest estimates and did not provide clear evidence of a between-group difference overall (p=0.21)
Nutrition (approx.): 200 calories | 26g protein | 9g fat | 1g carbs 9